| Homo sapiens |
3-phosphoinositide dependent protein kinase-1 |
Activity |
90.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
A549 |
IC50 |
10000.0 |
nM |
10.1021/np9003849 |
| Homo sapiens |
AMP-activated protein kinase, AMPK |
Activity |
16.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
ASPC1 |
GI50 |
21000.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
BR serine/threonine-protein kinase 1 |
Activity |
36.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
BR serine/threonine-protein kinase 2 |
Activity |
65.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Caco-2 |
GI |
12.0 |
% |
10.1021/acs.jmedchem.7b01765 |
| Homo sapiens |
Caco-2 |
GI50 |
25000.0 |
nM |
10.1021/acs.jmedchem.7b01765 |
| Homo sapiens |
CaM kinase I alpha |
Activity |
76.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
CaM-kinase kinase beta |
Activity |
18.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Casein kinase I delta |
Activity |
78.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Casein kinase I gamma 2 |
Activity |
92.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Casein kinase II |
Activity |
90.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
CDK2/Cyclin A2 |
Activity |
16.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
CDK2/Cyclin A2 |
IC50 |
7300.0 |
nM |
10.1016/j.bmc.2019.01.027 |
| Homo sapiens |
CDK2/Cyclin A2 |
IC50 |
7300.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
CDK2/Cyclin A2 |
IC50 |
7300.0 |
nM |
10.1021/acs.jmedchem.7b01765 |
| Homo sapiens |
CDK2/Cyclin A2 |
Inhibition |
10.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
CDK2/Cyclin A2 |
Inhibition |
10.0 |
% |
10.1021/acs.jmedchem.7b01765 |
| Homo sapiens |
CDK9/cyclin T1 |
Activity |
7.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
CDK9/cyclin T1 |
IC50 |
300.0 |
nM |
10.1016/j.bmc.2019.01.027 |
| Homo sapiens |
CDK9/cyclin T1 |
IC50 |
300.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
CDK9/cyclin T1 |
IC50 |
300.0 |
nM |
10.1021/acs.jmedchem.7b01765 |
| Homo sapiens |
CDK9/cyclin T1 |
Inhibition |
75.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
CDK9/cyclin T1 |
Inhibition |
75.0 |
% |
10.1021/acs.jmedchem.7b01765 |
| Homo sapiens |
c-Jun N-terminal kinase 1 |
Activity |
96.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
c-Jun N-terminal kinase 2 |
Activity |
107.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
c-Jun N-terminal kinase 3 |
Activity |
87.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Death-associated protein kinase 1 |
Activity |
96.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Discoidin domain-containing receptor 2 |
Activity |
79.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Dual specificity mitogen-activated protein kinase kinase 1 |
Activity |
27.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Dual specificity mitogen-activated protein kinase kinase 2 |
Activity |
44.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Dual specificity mitogen-activated protein kinase kinase 6 |
Activity |
89.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Dual specificity protein kinase CLK2 |
Activity |
45.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Dual specificity protein kinase TTK |
Activity |
56.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Dual specificity testis-specific protein kinase 1 |
Activity |
88.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A |
Activity |
27.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Dual-specificity tyrosine-phosphorylation regulated kinase 2 |
Activity |
84.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Dual-specificity tyrosine-phosphorylation regulated kinase 3 |
Activity |
77.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Ephrin type-A receptor 2 |
Activity |
38.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Ephrin type-A receptor 4 |
Activity |
53.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Ephrin type-B receptor 1 |
Activity |
54.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Ephrin type-B receptor 2 |
Activity |
81.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Ephrin type-B receptor 3 |
Activity |
82.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Ephrin type-B receptor 4 |
Activity |
84.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Eukaryotic translation initiation factor 2-alpha kinase 3 |
Activity |
82.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Fibroblast growth factor receptor 1 |
Activity |
66.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
Activity |
66.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
HCT-116 |
IC50 |
8800.0 |
nM |
10.1021/np9003849 |
| Homo sapiens |
HEK293 |
GI50 |
50000.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Hexokinase type IV |
Activity |
17.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
HL-60 |
Activity |
1.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
HL-60 |
Activity |
4.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
HL-60 |
Activity |
10.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
HL-60 |
GI |
83.0 |
% |
10.1021/acs.jmedchem.7b01765 |
| Homo sapiens |
HL-60 |
GI50 |
10000.0 |
nM |
10.1021/acs.jmedchem.7b01765 |
| Homo sapiens |
HL-60 |
IC50 |
7500.0 |
nM |
10.1021/np9003849 |
| Homo sapiens |
Homeodomain-interacting protein kinase 1 |
Activity |
96.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Homeodomain-interacting protein kinase 2 |
Activity |
76.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Homeodomain-interacting protein kinase 3 |
Activity |
100.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Inhibitor of nuclear factor kappa B kinase beta subunit |
Activity |
83.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Inhibitor of nuclear factor kappa B kinase epsilon subunit |
Activity |
69.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Insulin-like growth factor I receptor |
Activity |
113.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Insulin receptor |
Activity |
91.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Insulin receptor-related protein |
Activity |
53.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Interleukin-1 receptor-associated kinase 1 |
Activity |
55.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Interleukin-1 receptor-associated kinase 4 |
Activity |
75.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
K562 |
GI50 |
24000.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
LNCaP |
GI50 |
30000.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
MAP kinase-activated protein kinase 2 |
Activity |
52.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
MAP kinase-activated protein kinase 3 |
Activity |
83.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
MAP kinase-activated protein kinase 5 |
Activity |
72.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
MAP kinase ERK1 |
Activity |
86.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
MAP kinase ERK2 |
Activity |
90.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
MAP kinase-interacting serine/threonine-protein kinase MNK1 |
Activity |
88.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
MAP kinase p38 alpha |
Activity |
69.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
MAP kinase p38 beta |
Activity |
76.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
MAP kinase p38 delta |
Activity |
16.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
MAP kinase p38 gamma |
Activity |
27.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
MAP kinase signal-integrating kinase 2 |
Activity |
49.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
MAP/microtubule affinity-regulating kinase 2 |
Activity |
69.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
MAP/microtubule affinity-regulating kinase 4 |
Activity |
92.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Maternal embryonic leucine zipper kinase |
Activity |
80.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
MCF7 |
GI |
15.0 |
% |
10.1021/acs.jmedchem.7b01765 |
| Homo sapiens |
MCF7 |
GI50 |
28000.0 |
nM |
10.1021/acs.jmedchem.7b01765 |
| Homo sapiens |
MCF7 |
IC50 |
10000.0 |
nM |
10.1021/np9003849 |
| Homo sapiens |
MDA-MB-231 |
GI50 |
13000.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
MDA-MB-468 |
GI50 |
17000.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
MIA PaCa-2 |
GI |
2.0 |
% |
10.1021/acs.jmedchem.7b01765 |
| Homo sapiens |
MIA PaCa-2 |
GI50 |
19000.0 |
nM |
10.1021/acs.jmedchem.7b01765 |
| Homo sapiens |
Misshapen-like kinase 1 |
Activity |
73.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Mitogen-activated protein kinase 15 |
Activity |
19.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase 1 |
Activity |
47.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase 1 |
Activity |
83.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase 11 |
Activity |
58.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase 5 |
Activity |
96.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase 7 |
Activity |
70.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Myosin light chain kinase, smooth muscle |
Activity |
78.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
NCI-H226 |
IC50 |
10000.0 |
nM |
10.1021/np9003849 |
| Homo sapiens |
Nerve growth factor receptor Trk-A |
Activity |
89.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
NUAK family SNF1-like kinase 1 |
Activity |
52.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
PC-3 |
GI |
33.0 |
% |
10.1021/acs.jmedchem.7b01765 |
| Homo sapiens |
PC-3 |
GI50 |
19000.0 |
nM |
10.1021/acs.jmedchem.7b01765 |
| Homo sapiens |
Phosphorylase kinase |
Activity |
23.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Protein kinase C alpha |
Activity |
78.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Protein kinase C gamma |
Activity |
89.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Protein kinase C mu |
Activity |
75.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Protein kinase C zeta |
Activity |
118.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Protein kinase N2 |
Activity |
42.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
PSN1 |
GI50 |
23000.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-4 |
Activity |
79.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Ribosomal protein S6 kinase 1 |
Activity |
79.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Ribosomal protein S6 kinase alpha 1 |
Activity |
31.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Ribosomal protein S6 kinase alpha 2 |
Activity |
45.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Ribosomal protein S6 kinase alpha 5 |
Activity |
30.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase 11 |
Activity |
59.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase 16 |
Activity |
87.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase 24 |
Activity |
85.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase 33 |
Activity |
54.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase AKT |
Activity |
76.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase AKT2 |
Activity |
80.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-A |
Activity |
91.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase Aurora-B |
Activity |
58.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase Chk1 |
Activity |
52.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase Chk2 |
Activity |
60.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase c-TAK1 |
Activity |
41.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase EEF2K |
Activity |
84.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase MARK1 |
Activity |
67.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase MST2 |
Activity |
46.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase MST4 |
Activity |
68.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase NEK2 |
Activity |
89.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase NEK6 |
Activity |
84.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase OSR1 |
Activity |
93.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase PAK 2 |
Activity |
88.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase PAK 4 |
Activity |
83.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase PAK6 |
Activity |
79.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase PAK7 |
Activity |
87.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase PIM1 |
Activity |
27.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase PIM2 |
Activity |
67.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase PIM3 |
Activity |
12.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase PLK1 |
Activity |
96.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase RIPK2 |
Activity |
63.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase Sgk1 |
Activity |
92.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase SIK2 |
Activity |
19.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase SIK3 |
Activity |
28.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase SRPK1 |
Activity |
40.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase TAO1 |
Activity |
39.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase TBK1 |
Activity |
55.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase tousled-like 1 |
Activity |
109.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Serine/threonine-protein kinase WNK1 |
Activity |
100.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
T47D |
GI50 |
24000.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Tau-tubulin kinase 1 |
Activity |
82.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Testis-specific serine/threonine-protein kinase 1 |
Activity |
81.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Tyrosine-protein kinase ABL |
Activity |
87.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Tyrosine-protein kinase BRK |
Activity |
93.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Tyrosine-protein kinase BTK |
Activity |
58.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Tyrosine-protein kinase CSK |
Activity |
79.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Tyrosine-protein kinase JAK2 |
Activity |
41.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Activity |
45.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Tyrosine-protein kinase SRC |
Activity |
61.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Tyrosine-protein kinase SYK |
Activity |
109.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Tyrosine-protein kinase TIE-2 |
Activity |
80.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Tyrosine-protein kinase YES |
Activity |
57.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Tyrosine-protein kinase ZAP-70 |
Activity |
103.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
U-251 |
GI50 |
32000.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| Homo sapiens |
Vascular endothelial growth factor receptor |
Activity |
18.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
2.5 |
mg.kg-1 |
10.1021/acs.jnatprod.5b00947 |
| Rattus norvegicus |
Rho-associated protein kinase 2 |
Activity |
64.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| None |
ADMET |
GI50 |
50000.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| None |
ADMET |
Solubility |
18905.0 |
ug.mL-1 |
10.1016/j.bmcl.2016.06.046 |
| None |
ADMET |
Solubility |
33366.0 |
ug.mL-1 |
10.1016/j.bmcl.2016.06.046 |
| None |
Molecular identity unknown |
Activity |
4.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| None |
Molecular identity unknown |
Activity |
11.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| None |
Molecular identity unknown |
Activity |
13.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| None |
Molecular identity unknown |
Activity |
34.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| None |
Molecular identity unknown |
Activity |
43.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| None |
Molecular identity unknown |
Activity |
48.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| None |
Molecular identity unknown |
Activity |
50.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| None |
Molecular identity unknown |
Activity |
56.0 |
% |
10.1016/j.bmcl.2016.06.046 |
| None |
NON-PROTEIN TARGET |
GI50 |
10000.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| None |
NON-PROTEIN TARGET |
GI50 |
12000.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| None |
NON-PROTEIN TARGET |
GI50 |
19000.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| None |
NON-PROTEIN TARGET |
GI50 |
20000.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| None |
NON-PROTEIN TARGET |
GI50 |
22000.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| None |
NON-PROTEIN TARGET |
GI50 |
26000.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| None |
NON-PROTEIN TARGET |
GI50 |
27000.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| None |
NON-PROTEIN TARGET |
GI50 |
28000.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| None |
NON-PROTEIN TARGET |
GI50 |
30000.0 |
nM |
10.1016/j.bmcl.2016.06.046 |
| None |
No relevant target |
Drug degradation |
2.42 |
% |
10.1016/j.bmcl.2016.06.046 |
| None |
No relevant target |
LogD |
-0.55 |
None |
10.1016/j.bmcl.2016.06.046 |
| None |
No relevant target |
LogP |
-0.55 |
None |
10.1016/j.bmcl.2016.06.046 |
| None |
No relevant target |
LogP |
0.73 |
None |
10.1016/j.bmcl.2016.06.046 |
| None |
No relevant target |
LogP |
1.01 |
None |
10.1016/j.bmcl.2016.06.046 |
| None |
No relevant target |
pKa |
5.83 |
None |
10.1016/j.bmcl.2016.06.046 |
| None |
No relevant target |
Solubility |
10246.0 |
ug.mL-1 |
10.1016/j.bmcl.2016.06.046 |
| None |
No relevant target |
Solubility |
16936.0 |
ug.mL-1 |
10.1016/j.bmcl.2016.06.046 |
| None |
No relevant target |
Stability |
nan |
% |
10.1016/j.bmcl.2016.06.046 |
| None |
Unchecked |
Activity |
88.0 |
% |
10.1016/j.bmcl.2016.06.046 |